Prof. Peter Johnson, CBE, on accelerating cancer trials in the UK
In five years, we hope to have a national system for prescreening to determine eligibility for experimental cancer medicine, allowing the UK to
In five years, we hope to have a national system for prescreening to determine eligibility for experimental cancer medicine, allowing the UK to
The DIDACT Foundation was established with the mission to expand structured training and mentoring opportunities in clinical trial delivery for trainee UK haematologists.
SOHO UK is intended to set a precedent as the start of a continuing platform that will return at regular intervals and provide
Prof. Kate Cwynarski, MD, PhD, joined SOHO Insider podcast host Megan Melody, MD, for a discussion previewing lymphoma sessions she will lead at
Patients in the TRANSCEND FL study received liso-cel after lymphodepleting chemotherapy (LDC). Bridging therapy was allowed with reconfirmation of PET-positive disease before LDC.
Prof. Charlie Craddock, CBE, discusses what to expect at the first SOHO UK, which will be held 3–4 March 2026 in London at
Live session held on February 11, 2026, from 2:00–2:30 PM CST with speaker Tara Graff presenting on "Implementing Bispecific Antibodies in Community Practice."
In this video from SOHO Asia 2026, Dr. DiPersio discusses highlights from the acute myeloid leukemia session with Drs. Andrew Wei, Naval Daver,
SOHO invites delegates and attendees to submit an abstract for a poster or oral presentation during the Fourteenth Annual Meeting of the Society